{"id":"c0286a3c-e0c2-4f58-80ac-da9b4ebe169a","slug":"sol-reisberg","name":"Sol Reisberg","bioBrief":"Co-founder and Chief Scientific Officer of Warp Sciences; medicinal chemist, formerly at Gilead and Schrodinger.","priorExits":null,"nationality":null,"verificationPosture":"reported","aliases":[],"sources":[{"url":"https://lsvp.com/stories/why-were-backing-warp/","title":"Why We're Backing Warp","sourceName":"Lightspeed Venture Partners","publishedAt":"2026-10-22"},{"url":"https://www.signalfire.com/blog/warp-sciences-investor","title":"Why SignalFire is betting on Warp Sciences to accelerate U.S. drug discovery","sourceName":"SignalFire","publishedAt":"2026-10-22"}],"reviewStatus":"unreviewed","createdAt":"2026-10-22T21:01:59.337Z","updatedAt":"2026-10-22T21:01:59.337Z","educations":[],"companyRoles":[{"id":"d7df9e13-8da7-480e-894a-48c392bd6a2a","personId":"c0286a3c-e0c2-4f58-80ac-da9b4ebe169a","companyId":"62211703-9a1d-47f2-a338-041785a67a72","role":"chief_scientist","roleTitle":"Co-founder and CSO","startDate":null,"endDate":null,"currentRole":true,"roleBasis":"verified_secondary","displayOrder":null,"createdAt":"2026-10-22T21:02:02.407Z","company":{"slug":"warp-sciences","name":"Warp Sciences"}}],"boardRoles":[],"investorRoles":[],"foundings":[{"id":"74f2e11f-086f-487c-8d1f-0b4b7cd324ba","personId":"c0286a3c-e0c2-4f58-80ac-da9b4ebe169a","companyId":"62211703-9a1d-47f2-a338-041785a67a72","foundingDate":null,"cofounderStatus":"cofounder","stillAtCompany":true,"createdAt":"2026-10-22T21:02:00.906Z","company":{"slug":"warp-sciences","name":"Warp Sciences"}}]}